Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 15/20 | 0.59 |
| ▸ | ESR1 | P03372 | 14/20 | 0.59 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.39 |
| ▸ | ESRRB | O95718 | 1/20 | 0.38 |
| ▸ | ESRRA | P11474 | 1/20 | 0.38 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.37 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3922895 | 0.82 | ESR2 (0.51) | ESR2ESR1ESRRBESRRAPDE3B | |
| SCHEMBL3928207 | 0.75 | ESR1 (1.00) | ESR2ESR1ESRRBESRRA | |
| SCHEMBL27905510 | 0.71 | PDE3B (0.46) | ESR2ESR1ESRRBESRRAPDE3B | |
| SCHEMBL27638492 | 0.69 | ESR2 (0.43) | ESR2ESR1 | |
| SCHEMBL28211226 | 0.68 | ESR1 (0.42) | ESR2ESR1ESRRBESRRAPDE3B | |
| SCHEMBL3934682 | 0.66 | ESR1 (1.00) | ESR2ESR1 | |
| SCHEMBL3044443 | 0.66 | ESR2 (0.54) | ESR2ESR1PDE3BPDE3A | |
| SCHEMBL1289652 | 0.65 | KDM4E (0.50) | DHODH | |
| SCHEMBL3557738 | 0.65 | PIM1 (0.43) | ESR2ESR1ESRRBESRRAPDE3B | |
| SCHEMBL15552163 | 0.64 | ESR1 (0.48) | ESR2ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009009417-A2 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION | WYETH (US) | 2009-01-15 | — | — | WO | disclosed |